Company: LNAI
Filing Date: 2025-10-15
Form Type: DEF 14A
Source: 0001731122-25-001378
Chunk: 71

Company: Lunai Bioworks Inc.
Filing Date: 2025-10-15
Form: DEF 14A
Chunk 71
---
 Option Price; provided, however,
that the SAR Exercise Price may not be less than the Fair Market Value of a Share on the Grant Date of the SAR to the extent required
by Section 409A.\

| 11. | Section 15.1 of the Plan is amended and restated to read: |

| 15.1. | Changes in Common Stock |

If (i)
the number of outstanding Shares is increased or decreased or the Shares are changed into or exchanged for a different number or kind
of shares or other securities of the Company on account of any recapitalization, reclassification, stock split, reverse split, combination
of shares, exchange of shares, stock dividend or other distribution payable in capital stock, or other increase or decrease in such Shares
effected without receipt of consideration by the Company occurring after the Effective Date or (ii) there occurs any spin-off, split-up,
extraordinary cash dividend, or other distribution of assets by the Company, (A) the number and kinds of shares for which grants of Awards
may be made (including the per-Grantee maximums set forth in Section 4), (B) the number and kinds of shares for which
outstanding Awards may be exercised or settled, and (C) the performance goals relating to outstanding Awards, shall be equitably adjusted
by the Company (subject to approval of the Board or the Committee to the extent required), and (D) the total number of shares reserved
for issuance under the Plan shall be equitably adjusted by the Company so that the quotient of (x) such total number of shares immediately
prior to such event and (y) the number of shares of Common Stock immediately prior to such event equals the quotient of (x) such total
number of shares immediately after such event and (y) the number of shares of Common Stock outstanding immediately after such event, subject
in each case to the approval of the Board to the extent required and, in any event, in compliance with Sections 409A and 422. In addition,
in the event of any such increase or decrease in the number of outstanding shares or other transaction described in clause (ii) above,
the number and kind of shares for which Awards are outstanding and the Option Price per share of outstanding Options and SAR Exercise
Price per share of outstanding SARs shall be equitably adjusted so that the same proportion of issued and outstanding shares remains subject
to exercise at the same aggregate exercise price, and any adjustment shall result only in whole shares;